Gefitinib and Methotrexate to Treat Ectopic Pregnancies with a Pre-Treatment Serum hCG 1000–10,000 IU/L: Phase II Open Label, Single Arm Multi-Centre Trial

  • Monika M. Skubisz
  • , Stephen Tong*
  • , Ann Doust
  • , Jill Mollison
  • , Terrance G. Johns
  • , Peter Neil
  • , Miranda Robinson
  • , Siladitya Bhattacharya
  • , Euan Wallace
  • , Nicole Krzys
  • , W. Colin Duncan
  • , Andrew W. Horne
    • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

12 Citations (Scopus)
11 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Gefitinib and Methotrexate to Treat Ectopic Pregnancies with a Pre-Treatment Serum hCG 1000–10,000 IU/L: Phase II Open Label, Single Arm Multi-Centre Trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases